10X Genomics, Inc.
(NASDAQ : TXG)

( )
TXG After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 8.42%419.050.0%$8674.93m
BNTXBioNTech SE 17.80%414.440.0%$1709.63m
NVAXNovavax, Inc. 18.69%223.8179.8%$898.59m
SNSSSunesis Pharmaceuticals, Inc. -0.92%10.720.7%$749.37m
AMGNAmgen, Inc. -6.46%228.311.3%$524.03m
BIIBBiogen, Inc. 0.03%338.101.7%$451.97m
VRTXVertex Pharmaceuticals, Inc. -0.23%199.591.9%$424.11m
GILDGilead Sciences, Inc. -0.85%69.241.0%$409.81m
REGNRegeneron Pharmaceuticals, Inc. -0.95%580.952.7%$330.19m
ILMNIllumina, Inc. 1.24%504.603.5%$271.58m
NTLAIntellia Therapeutics, Inc. 5.87%146.942.3%$204.93m
SGENSeagen Inc. 3.17%163.215.8%$137.56m
CRSPCRISPR Therapeutics AG 2.63%124.610.6%$137.02m
TBIOTranslate Bio, Inc. 0.48%37.853.3%$134.82m
EXASEXACT Sciences Corp. 1.56%105.8318.1%$131.45m

Company Profile

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.